Development of Merkel Cell Carcinoma in a Patient Receiving Rituximab

Merkel cell carcinoma (MCC) is a rare, rapidly growing, and aggressive dermatological neoplasm. It is commonly reported in Caucasian ethnicities, and almost 50% of the patients have a concomitant malignancy and are on immunosuppressive chemotherapy. Here, we present a 79-year-old woman with a histor...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonios, Bana, Karki, Ujjwal, Antonios, Kais, Ghimire, Bipin, Chisti, Mohammad Muhsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649309/
https://www.ncbi.nlm.nih.gov/pubmed/36394062
http://dx.doi.org/10.1155/2022/1814338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649309/
https://www.ncbi.nlm.nih.gov/pubmed/36394062
http://dx.doi.org/10.1155/2022/1814338

Ejemplares similares